Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Scientific Journal of Al-Azhar Medical Faculty [Girls] [The]. 2000; 21 (Supp. 1): 1111-1119
in English | IMEMR | ID: emr-55665

ABSTRACT

This study was performed on 30 NIDDM patients with complications [diabetic nephropathy and retinopathy], 20 NIDDM patients without complications and 20 age and sex-matched healthy control subjects. NIDDM patients with complications showed a highly significant increase of plasma vascular endothelial growth factor [VEGF] than other two groups. NIDDM patients without complications had a higher VEGF than the control subjects. VEGF was correlated with fasting, 2-hour postprandial blood glucose levels, glycosylated, hemoglobin [HbA1c] and albumin excretion rate [AER], but it was not correlated to the duration of DM


Subject(s)
Humans , Male , Female , Diabetic Retinopathy , Diabetic Nephropathies , Diabetic Angiopathies , Endothelium, Vascular , Endothelial Growth Factors
2.
Al-Azhar Medical Journal. 1999; 28 (3-4): 381-392
in English | IMEMR | ID: emr-50151

ABSTRACT

An early marker of subclinical arteriosclerosis, the increased intimal-medial thickness [IMT] of the common carotid artery was measured by B-mode ultrasound in twenty non-diabetic and thirty non- insulin- dependent diabetic patients [ten newly diagnosed and twenty well established diabetics]. This marker was compared in non- diabetic and diabetic subjects to evaluate its correlation with some cardiovascular risk factors, and duration of diabetes. In addition, body mass index [BMI], waist to hip ratio [WHR], blood pressure, glycosylated hemoglobin [HbAic] and fasting concentrations of plasma glucose, serum lipids and serum insulin were measured in all subjects. In conclusion, diabetes is characterized by a greater thickness of the carotid artery, which lead to increased risk of arteriosclerosis. Also, central adiposity is considered as a predictor of IMT in non- diabetic individuals


Subject(s)
Atherosclerosis , Carotid Arteries , Biomarkers , Triglycerides , Lipoproteins , Ultrasonography , Diabetes Mellitus, Type 2/complications
SELECTION OF CITATIONS
SEARCH DETAIL